These changes promote the activation of oncogenes, the damage of DNA and protein, the release of ROS, and affect multiple signaling pathways including STAT3, K-RAS, NF-κB, and P53 supporting tumor growth (8–10). The gene discussed is STAT3; the disease is neoplasm.